Results 21 to 30 of about 15,451 (202)

Macroprolactinemia: a mini-review and update on clinical practice

F&S Reports, 2023
Hyperprolactinemia is common among infertile patients, with up to 15%–20% of women with oligomenorrhea having hyperprolactinemia. Suppression of the hypothalamic-pituitary-gonadal axis via inhibition of pulsatile gonadotropin releasing hormone because of
Katherine Koniares, M.D., Claudio Benadiva, M.D., Lawrence Engmann, M.D., John Nulsen, M.D., Daniel Grow, M.D.   +4 more
doaj   +1 more source

Editorial: Insights in hyperprolactinemia

, 2023
Hyperprolactinemia is the most common endocrine disorder of the hypothalamicpituitary axis. Prolactin is synthesized by the anterior pituitary lactotroph cells and is regulated by various factors, with dopamine being the primary inhibitory factor.
Pineyro, Maria M., Maria M. Pineyro, Tamagno, Gianluca, Rulli, Susana B., Gianluca Tamagno, Susana B. Rulli   +5 more
core   +1 more source

Prolactinoma or leiomyoma-associated hyperprolactinemia—this is the question, a case report and review of the literature

Clinical and Experimental Obstetrics & Gynecology, 2022
Background: Hyperprolactinemia is a common finding in women of reproductive age that could result from physiological factors, pathological conditions or the use of different medications.
Ralitsa Robeva, Radina Ivanova, Teodora Kamenova, Atanaska Elenkova, Sabina Zacharieva   +4 more
doaj   +1 more source

Unusually High Prolactin Level for Medication-Induced Hyperprolactinemia: A Case Report

Eurasian Journal of Medicine, 2019
Hyperprolactinemia has a number of etiologies, including physiological, pathological and pharmacological causes. Hyperprolactinemia is frequently associated with the use of certain medications. Patients using medications known to cause hyperprolactinemia
Emin M. Akbas, Adem Gungor, Cigdem Ozdemir, Habib Bilen   +3 more
doaj   +1 more source

The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients

Kaohsiung Journal of Medical Sciences, 2012
This study investigated the differences in clinical and laboratory features as well as treatment response in 70 outpatients with macroprolactinemia and monomeric hyperprolactinemia treated with dopamine agonists.
Chih-Chin Lu, Ching-Jung Hsieh
doaj   +1 more source

Infertility after long-acting paliperidone palmitate treatment: A case report (tur)

Klinik Psikiyatri Dergisi, 2020
Hyperprolactinemia is a common side effect of antipsychotic treatments. Conventional antipsychotics increase prolactin secretion due to their strong D2 receptor antagonism and long-term dependence on the receptor.
Kerim Uğur, Sevler Yıldız
doaj   +1 more source

Acupuncture treatment for hyperprolactinemia [PDF]

, 2018
• Hyperprolactinemia is a disorder of the endocrine system that causes the body to produce higher levels of prolactin than normal. • Symptoms of hyperprolactinemia in women are: irregular menstrual cycle, production of breast milk in absence of ...
Ahtarova, Ivana, Kozovska, Kristina, Arsovska, Blagica, Zhu, Jihe   +3 more
core   +2 more sources

Association of Cadmium, Chromium, Manganese and Lead with Hyperprolactinemia: A Pilot Study [PDF]

Journal of Clinical and Diagnostic Research, 2020
Introduction: Hyperprolactinemia is one of the most common hypothalamic-pituitary dysfunctions where serum prolactin levels increase beyond normal range. Studies have suggested association of heavy metals with prolactin levels.
Amanpreet Kaur Kalsi, Ashutosh Halder, Manish Jain, Amita Srivastava   +3 more
doaj   +1 more source

Missed miscarriage and hyperprolactinemia. Is there a place for plant-derived medicines? [PDF]

РМЖ. Мать и дитя, 2020
Missed miscarriage and hyperprolactinemia. Is there a place for plant-derived medicines? A.A. Olina D.O. Ott Research Institute of Obstetrics, Gynaecology and Reproduction, St.
A.A. Olina
doaj  

Mild hyperprolactinemia in women with polycystic ovary syndrome. Insights from a large cross-sectional study

Journal of Clinical & Translational Endocrinology
Background: Hyperprolactinemia is an exclusion criterion for polycystic ovary syndrome (PCOS), albeit PCOS itself is argued to induce mild hyperprolactinemia.
Manuel Luque-Ramírez, Alejandra Quintero-Tobar, María Ángeles Martínez-García, Sara de Lope Quiñones, María Insenser, Lía Nattero-Chávez, Héctor Francisco Escobar-Morreale   +6 more
doaj   +1 more source